Back to Search Start Over

Oral Presentations.

Source :
Pediatric Dermatology. May2023 Supplement 1, Vol. 40, p4-9. 6p.
Publication Year :
2023

Abstract

PCR and culture turned negative simultaneously on systemic therapy except for 2 patients (15%), where PCR turned negative 4 weeks after culture without continued systemic therapy. To our knowledge, this is the first description of topical 5-fluorouracil being used as an effective treatment for trichodysplasia spinulosa and, pending confirmation, may represent a more cost-effective and widely available treatment than topical cidofivir. Efficacy and safety of dupilumab treatment up to 1 year in infants and preschool children wit... Michael J. Cork 1, Amy S. Paller 2,3, Elaine C. Siegfried 4,5, Jing Xiao 6, Randy Prescil... 1 Sheffield Dermatology Research, University of Sheffield Sheffield Children's Hospital, Shef... B Objectives: b To report dupilumab efficacy and safety in children aged from 6 months to 5 years with moderate-to-severe atopic dermatitis (AD) treated for up to 1 year. B Discussion: b Dupilumab treatment for 1 year provides sustained improvement in signs of AD and quality of life with an acceptable safety profile in patients aged from 6 months to 5 years with moderate-to-severe AD. [Extracted from the article]

Details

Language :
English
ISSN :
07368046
Volume :
40
Database :
Academic Search Index
Journal :
Pediatric Dermatology
Publication Type :
Academic Journal
Accession number :
163283734
Full Text :
https://doi.org/10.1111/pde.15300